Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Dalteparin
×
1 year
×
Clear all
Filters
3
NCT05171075
2026-04-17
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3
Terminated
417 enrolled
NCT03045406
2025-06-24
CARAVAGGIO
Fadoi Foundation, Italy
Phase 3
Completed
1,170 enrolled
11 charts